Citations

Clear

2960 citation(s) found for "Kim, P".

Predictors of achieving Neck Disability Index minimum clinically important difference following cervical deformity surgery
Mikula, Anthony L., Scheer, Justin K., Turner, Jay D., Lafage, Renaud, Lafage, Virginie, Kebaish, Khaled , Klineberg, Eric O., Mundis, Gregory M., Daniels, Alan H., Eastlack, Robert K. , Lewis, Stephen M., Protopsaltis, Themistocles S., Soroceanu, Alex, Gupta, Munish C., Kim, Han Jo, Kelly, Michael P., Lenke, Lawrence G., Shaffrey, Christopher I., Bess, Shay R., Smith, Justin S., Ames, Christopher P., Mikula, Anthony L. , Scheer, Justin K. , Kumar, Rahul Robaish , Turner, Jay D. , Mullin, Jeffrey P. , Lafage, Renaud , Lafage, Virginie , Kebaish, Khaled M. , Klineberg, Eric O. , Mundis, Gregory M. , Daniels, Alan H. , Lewis, Stephen M., Protopsaltis, Themistocles S. , Gupta, Munish C , Kim, Han Jo , Kelly, Michael P. , Lenke, Lawrence G. , Shaffrey, Christopher I. , Bess, Shay R. , Smith, Justin S. , Ames, Christopher Pearson

Mayo Clinic

Journal of Neurosurgery: Spine | January 22, 2026 | Volume: 44 | Issue: 4 | Pages: 581-588

10.3171/2025.9.spine25668 | PMID 41569694 Get It

OBJECTIVE The aim of this study was to determine predictors of the minimum clinically important difference (MCID) in the Neck Disability Index (NDI) following cervical spinal deformity surgery. METHODS A retrospective review was performed of a prospective, multicenter adult cervical spinal deformity database. All patients had baseline and 1-year NDI scores. Patients met MCID with an improvement of NDI by 7 points between baseline and 1 year, as previously established. Baseline demographics, comorbidities, and both baseline and 1-year spinopelvic parameters were evaluated for statistical significance in a univariate logistic regression analysis. Significant variables, in addition to baseline NDI, were analyzed in a multivariable logistic regression model by backward selection with Akaike information criterion minimization. RESULTS A total of 122 patients were included with a median age of 62 (IQR 56, 69) years; 62% of patients were female. Of the 122 patients, 72 (59%) achieved NDI MCID at 1 year. Predictors of achieving MCID on univariate analysis included a lower Charlson Comorbidity Index (CCI) total score (OR 0.70, p = 0.03), depression as a comorbidity (OR 2.9, p = 0.02), lower C2 tilt at the 1-year follow-up (OR 0.92, p = 0.02), and a greater difference between 1-year postoperative C2–7 sagittal vertical axis (SVA) and preoperative C2–7 SVA (OR 0.98, p = 0.0495). On multivariable logistic regression analysis, predictors of achieving MCID included a lower CCI (OR 0.62, p = 0.03), depression as a comorbidity (OR 3.1, p = 0.059), a greater change in C2–7 SVA at the 1-year follow-up compared with baseline (OR 0.97, p = 0.055), and baseline NDI (OR 1.02, p = 0.24) with an area under the curve of 0.74. CONCLUSIONS The best-fit multivariable model included higher baseline NDI, a greater change in C2–7 SVA, patient-reported baseline depression, and lower CCI as important factors in predicting NDI MCID.
Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model
Li, Zhihao, Centonze, Leonardo , Raptis, Dimitri , Marquez, Kris Ann Hervera , Rammohan, Ashwin, Gunasekaran, Vasanthakumar , Hong, Suyoung , Chen, I Lun, KIM, Jongman , Hsu, Shih-Chao , Akamatsu, Nobuhisa, Shaked, Oren, Genedy, Lara, Dutkowski, Philipp , Nadalin, Silvio, Boehnert, Markus U, Mathur, Abhishek, Emond, J., Testa, Giuliano, Olthoff, Kim, Taner, Timucin, Wong, Tiffany CL, Hasegawa, Kiyoshi, Balci, D., Cattral, Mark, Sapisochin, G., Selzner, Nazia, Jeng, Long-Bin, Chen, Chao-Long, Suh, Kyung-Suk, Rela, Mohamed, Broering, Dieter, Clavien, Pierre-Alain, Kim, Jong Man , Raptis, Dimitri Aristotle , Li, Zhihao , Hong, Su young , Chen, I. , Centonze, Leonardo , Li, Zhihao , Rammohan, Ashwin , Chen, Itsuko Chih-Yi , Kirimker, Elvan Onur , Akamatsu, Nobuhisa , Shaked, Oren , Finotti, Michele , Yeow, Marcus , Nadalin, Silvio , Boehnert, Markus U , Polak, Wojciech G , Bonney, Glenn K , Samstein, Benjamin , Emond, Jean C , Testa, Giuliano , Olthoff, Kim M , Heimbach, Julie K , Taner, Timucin , Wong, Tiffany C L , Balci, Deniz , Cattral, Mark , Sapisochin, Gonzalo , Selzner, Nazia , Jeng, Long-Bin , Joh, Jae-Won , Chen, Chao-Long , Suh, Kyung-Suk , Di Sandro, Stefano , Rela, Mohamed , Broering, Dieter , Clavien, Pierre-Alain , Akamatsu, Nobuhisa , Shaked, Oren , Boehnert, Markus , Polak, Wojciech G. , Mathur, Abhishek , Samstein, Benjamin , Emond, Jean C. , Testa, Giuliano , Heimbach, Julie K. , Taner, Timuçin , Wong, Tiffany , Hasegawa, Kiyoshi , Cattral, Mark S. , Sapisochín, Gonzalo , Selzner, Nazia , Joh, Jae‐Won , Rela, Mohamed , Bröering, Dieter C. , Clavien, Pierre‐Alain

Mayo Clinic

Liver Transplantation | January 21, 2026 | Volume: 32 | Issue: 7 | Pages: 1027-1039

10.1097/lvt.0000000000000816 | PMID 41564353 Get It

Early allograft failure (EAF) after living donor liver transplantation (LDLT) remains a clinical challenge. Existing prediction models developed for deceased donor transplantation poorly apply to LDLT due to distinct surgical and physiological factors. This study identifies clinical determinants of EAF and develops an LDLT-specific prediction model. We conducted a multicenter retrospective cohort study from 17 high-volume LDLT centers (January 2016–December 2020) with external validation at a tertiary center in Saudi Arabia (January 2015–December 2022). The primary outcome was EAF (graft loss or patient death ≤90 d). Multivariable mixed-effects logistic regression identified preoperative/intraoperative risk factors. The EAGLE-LDLT model was constructed using postoperative laboratory values. Performance was compared against established models (EAD, MEAF, A2ALL) using ROC analysis and decision curve analysis. The development cohort included 2944 adult LDLT recipients (67.7% male; median age 55 y; median MELD 14) with a 5.5% EAF rate. External validation included 1020 recipients (median MELD 21, 6.7% EAF). Independent risk factors for EAF were MELD (OR 1.06, 95% CI 1.04–1.08), donor BMI (OR 1.05, 95% CI 1.00–1.10), portal vein thrombosis (OR 1.73, 95% CI 1.13–2.63), and hepaticojejunostomy (OR 1.58, 95% CI 1.06–2.36). The EAGLE-LDLT model incorporating peak ALT (>468 U/L), peak INR (>1.9), and bilirubin (>3.5 mg/dL) and INR (>1.3) at POD7, demonstrated superior discrimination (AUC=0.81) compared with MEAF (AUC=0.77, p =0.004), EAD (AUC=0.67, p <0.001), and A2ALL (AUC=0.65, p <0.001). EAGLE-LDLT achieved balanced sensitivity (75.0%) and specificity (73.7%), effectively stratifying patients into high-risk (15% of patients; 40.4% EAF incidence) and low-risk groups. Preoperative and intraoperative clinical factors predict EAF in LDLT. The EAGLE-LDLT model accurately identifies LDLT recipients at the highest risk for EAF postoperatively.
Conventional versus advanced imaging selection for endovascular treatment of basilar artery occlusion strokes
Chen, Huanwen , Colasurdo, Marco, Matsukawa, Hidetoshi, Cunningham, Conor, Maier, Ilko , Kasab, Sami Al, Jabbour, Pascal , Kim, Joon-Tae, Wolfe, Stacey Quintero, Rai, Ansaar, Starke, Robert M, Psychogios, Marios-Nikos, Goyal, Nitin, Yoshimura, Shinichi, Cuellar, Hugo, Grossberg, Jonathan A, Alawieh, Ali, Alaraj, Ali, Ezzeldin, Mohamad, Romano, Daniele G, Tanweer, Omar, Mascitelli, Justin, Fragata, Isabel, Polifka, Adam, Siddiqui, Fazeel, Osbun, Joshua, Crosa, Roberto, Matouk, Charles, Park, Min S, Levitt, Michael R, Brinjikji, Waleed, Moss, Mark, Dumont, Travis, Daglioglu, Ergun, Williamson, Richard, Navia, Pedro, Leacy, Reade De, Chowdhry, Shakeel, Altschul, David J, Spiotta, Alejandro M, Kan, Peter, Wolfe, Stacey Q , Alaraj, Ali , Altschul, David , Samaniego, Edgar A , Jabbour, Pascal , Alaraj, Ali , Altschul, David J , Wolfe, Stacey Quintero , Chen, Huanwen , Colasurdo, Marco, Matsukawa, Hidetoshi, Cunningham, Conor, Kasab, Sami Al, Kim, Joon-Tae, Wolfe, Stacey Quintero, Rai, Ansaar, Starke, Robert M, Psychogios, Marios‐Nikos , Goyal, Nitin, Yoshimura, Shinichi, Cuellar, Hugo, Grossberg, Jonathan A, Alawieh, Ali, Ezzeldin, Mohamad, Romano, Daniele G, Tanweer, Omar, Mascitelli, Justin, Fragata, Isabel, Polifka, Adam, Siddiqui, Fazeel, Osbun, Joshua, Crosa, Roberto, Matouk, Charles, Park, Min S, Levitt, Michael R, Brinjikji, Waleed, Moss, Mark, Dumont, Travis, Daglioglu, Ergun, Williamson, Richard, Navia, Pedro, Leacy, Reade De, Chowdhry, Shakeel, Spiotta, Alejandro M, Kan, Peter

Mayo Clinic

European Stroke Journal | January 20, 2026 | Volume: 11 | Issue: 1 | Pages: No page available

10.1093/esj/23969873251364973 | PMID 41614473 Get It

Abstract Introduction Endovascular thrombectomy (EVT) is an effective treatment for basilar artery occlusion (BAO) stroke in select patients. While there is a growing body of literature suggesting that advanced imaging modalities such as computed tomography perfusion (CTP) and magnetic resonance (MR) may not be necessary for selecting anterior circulation large vessel occlusion stroke patients for EVT, whether advanced imaging may be superior to conventional imaging (non-contrast CT and CT angiography) in identifying good treatment candidates among BAO patients is less clear. Patients and methods This was a multicenter retrospective cohort study of BAO EVT patients treated from 2013 to 2022 in the Stroke Thrombectomy and Aneurysm Registry. Patients selected for EVT by advanced imaging (CTP or MR) were matched with those selected by conventional imaging using propensity score matching (PSM) accounting for possible confounders. Primary outcome was functional independence at 90 days. Other outcomes include bedridden state or death at 90-days and symptomatic intracranial hemorrhage (sICH). Results 268 patients were included. 150 patients were selected for BAO EVT by conventional imaging, 86 by CTP, and 32 by MR. Patients selected by advanced imaging were significantly older than those selected by conventional imaging (median age 71 vs 64 years, p = 0.001); patient characteristics were otherwise similar between cohorts. After PSM, 90-day outcomes were similar between the two cohorts (p = 0.56), with similar rates of functional independence (39.4% vs 35.1%, p = 0.65), bedridden state or death (40.4% vs 44.7%, p = 0.66), and sICH (3.3% vs 5.7%, p = 0.49) for conventional and advanced imaging groups, respectively. Results were similar across treatment time windows (all p &gt; 0.05). Conclusions Selecting patients for basilar EVT using conventional versus advanced imaging did not result in different clinical outcomes, regardless of treatment time windows. Conventional imaging appears sufficient as a first-line tool for selecting basilar EVT patients in routine clinical practice.
Frontline aspiration versus stent retriever thrombectomy for M2 occlusions: Insights from the STAR registry
Gaub, Michael , Kasem, Rahim Abo , Maier, Ilko , Rai, Ansaar, Jabbour, Pascal, Kim, Joon-Tae, Wolfe, Stacey Q , Starke, Robert M, Psychogios, Marios-Nikos, Goyal, Nitin, Dye, Justin , Alaraj, Ali, Ezzeldin, Mohamad , Yoshimura, Shinichi, Fiorella, David, Tanweer, Omar, Romano, Daniele G, Navia, Pedro, Cuellar, Hugo H, Polifka, Adam , Osbun, Joshua, Siddiqui, Fazeel , Moss, Mark, Mokin, Maxim, Matouk, Charles, Park, Min S, Brinjikji, Waleed, Dağlıoğlu, Ergün , Williamson, Richard, Altschul, D, Ogilvy, Christopher S, Levitt, Michael R, Gory, Benjamin, Paul, A, Kan, Peter, Casagrande, Walter, Chowdhry, Shakeel, Stiefel, Michael , Grandhi, Ramesh, Spiotta, Alejandro M , Mascitelli, Justin, Jabbour, Pascal , Ogilvy, Christopher S. , Alaraj, Ali , Altschul, David , Abo Kasem, Rahim , Jabbour, Pascal , Alaraj, Ali , Altschul, David J , Wolfe, Stacey Quintero , Ogilvy, Christopher S , Rai, Ansaar , Kim, Joon‐Tae , Howard, Brian M , Alawieh, Ali , Psychogios, Marios‐Nikos , Shaban, Amir , Fiorella, David , Tanweer, Omar , Romano, Daniele Giuseppe , Navía, Pedro , Fragata, Isabel , Osbun, Joshua W , Moss, Mark, Limaye, Kaustubh , Mokin, Maxim , Matouk, Charles , Brinjikji, Waleed , Williamson, Richard, Crosa, Roberto , Levitt, Michael R. , Gory, Benjamin , Paul, Alexandra R , Chowdhry, Shakeel , Grandhi, Ramesh , Mascitelli, Justin R

Mayo Clinic

European Stroke Journal | January 20, 2026 | Volume: 11 | Issue: 1 | Pages: No page available

10.1093/esj/23969873251381924 | PMID 41614461 Get It

Abstract Background Recent trials have furthered uncertainty regarding the endovascular benefit for medium vessel occlusions (MeVO). Stent retrievers (SR) were employed in the first attempt in most interventional arm participants. We sought to compare outcomes in acute MCA M2 occlusions between frontline aspiration and SR, and to delineate procedural and anatomical covariates associated with differential treatment effect. Methods Retrospective analysis of a multicenter stroke thrombectomy cohort identified cases of MT for M2 occlusions. Unmatched and propensity score-matched (PSM) cohorts were generated comparing frontline aspiration to standalone and combined SR. The primary outcome was functional independence (mRS 0–2) at 90 days. Recanalization, symptomatic intracranial hemorrhage (sICH), mortality, and the effect of M2 laterality, division occlusion and procedure time were assessed. Results About 1734 patients with M2 occlusions underwent either frontline aspiration (n = 711) or SR/combined (n = 958) thrombectomy between 2013 and 2024. PSM analysis favored aspiration for functional independence (49.9% vs 44.0%, OR 1.27 (1.03–1.57)), complete recanalization (61.2% vs 48.7%, OR 1.66 (1.34–2.05)), complete first pass effect (35.0% vs 27.6%, OR 1.42 (1.13–1.78)), and sICH (3.5% vs 6.2%, OR 0.55 (0.33–0.91)), with no difference in mortality. Frontline aspiration had significantly shorter procedural times (median 28 [IQR 15–49.5] vs 51 [IQR 35–78] minutes; p &lt; 0.001). For every minute increase in procedure time, the probability of functional independence decreased significantly (p &lt; 0.001) less with frontline aspiration (0.35%) compared to SR/combined (1.61%). Conclusion Frontline aspiration for M2 occlusions resulted in better clinical and angiographic outcomes compared to SRs. Future trials for MeVO with a focus on contact aspiration thrombectomy may succeed where recent trials have failed.
Masters athletes with abnormal cardiovascular findings: a clinical consensus statement of the European Association of Preventive Cardiology of the ESC and the American College of Cardiology
Eijsvogels, Thijs M H , Kim, Jonathan H. , Aengevaeren, Vincent L. , D’Ascenzi, Flavio , Churchill, Tim, Dineen, Elizabeth H. , Garza, M Sanz-De La, Gati, Sabiha , Hálasz, Géza , Haugaa, Kristina H. , Heidbüchel, Hein , Lampert, Robin, Krishnan, Sheela , Maestrini, V, Martinez, Matthew, Phelan, Dermot , Thompson, Paul D. , Churchill, Timothy W. , Churchill, Timothy W , Sanz-de la Garza, María , Haugaa, Kristina , La Gerche, Andre , Lampert, Rachel , Krishnan, Sheela , Maestrini, Viviana , Papadakis, Michael , Perone, Francesco , Phelan, Dermot , Sharma, Sanjay , Thompson, Paul D , Baggish, Aaron L , Claessen, Guido , Eijsvogels, Thijs M.H. , Gerche, André La , Martinez, Matthew W. , Perone, Francesco , Baggish, Aaron L.

Mayo Clinic

European Heart Journal | January 16, 2026 | Volume: 47 | Issue: 21 | Pages: 2541-2560

10.1093/eurheartj/ehag040 | PMID 41947397 Get It

Abstract Exercise training improves cardiovascular health and reduces the risk for future cardiovascular events and mortality. However, emerging evidence suggests that Masters athletes may have a higher prevalence of cardiovascular abnormalities, such as atrial arrhythmias, coronary atherosclerosis, aortic dilatation, and myocardial fibrosis, compared to their less active peers. The clinical management of Masters athletes may be challenging as available guidelines for such conditions are generally based on data derived from symptomatic sedentary patients, limiting their applicability to highly trained individuals. Other unique challenges in the clinical assessment of Masters athletes include differences in symptomatic presentations compared to sedentary individuals, potential resistance to the initiation of pharmacologic treatment, and the increasing availability of consumer wearable health data that may provide relevant information on their cardiovascular health status. The purpose of this joint EAPC/ESC and ACC Clinical Consensus Statement is to provide an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes. We present an expert-based approach on the diagnostic assessment, management, and prognosis of (i) atrial fibrillation, (ii) bradyarrhythmias, (iii) ventricular arrhythmias, (iv) coronary atherosclerosis, (v) aortic dilatation, (vi) myocardial fibrosis, and (vii) exercise-induced arrhythmogenic cardiomyopathy. Clinical challenges, areas of ongoing controversy, and uncertainty and the potential underlying mechanisms are discussed. We also present future perspectives and research directives to further refine current best practice strategies. This includes the need for clinical outcome studies, dedicated randomized controlled trials in athletes, and international registries with diverse populations and longitudinal follow-up to evaluate the natural history of cardiac abnormalities and facilitate development of evidence-based approaches in the clinical management of Masters athletes with cardiovascular abnormalities.
Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP
Best, Simon R. , Friedman, Aaron D. , Rosen, Clark A., Sataloff, Robert T. , Matrka, Laura , Sims, H. Steven , Rosow, David E. , Lott, David G., Mau, Ted, Wikenheiser‐Brokamp, Kathryn A., Norberg, Scott M. , McClellan, Kim, Young, Geoffrey D., ALLEN, C., Lott, David G. , Wikenheiser‐Brokamp, Kathryn A. , Mau, Ted , Rosen, Clark , Matrka, Laura , Lott, David G , Mau, Ted , Allen, Clint T , Amin, Milan R , Saba, Nabil F. , Klein, Adam M.

Mayo Clinic

The Laryngoscope | January 16, 2026 | Volume: 136 | Issue: S4 | Pages: No page available

10.1002/lary.70379 | PMID 41543033 Get It

ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm for adults with RRP considering published literature and commercial drug availability. Results Preventative HPV vaccination should be considered for all patients. Determination of HPV type and pulmonary imaging are important for contemporary RRP patient care and assist in decision making. Risks and benefits of papilloma debulking as needed versus medical management of RRP must be deliberated on a patient case‐by‐case basis. HPV ‐specific immunotherapy that induces an HPV ‐specific T cell response to target the underlying HPV infection that is the cause of RRP is safe, offers the possibility of durable disease control following a short treatment course and is the recommended first‐line medical treatment for patients who wish to avoid the risks of repeat procedural management. Papilloma disease control with systemic bevacizumab, which carries defined risks and must be continued for clinical benefit is the recommended second‐line medical treatment for patients who do not achieve a complete response with immunotherapy and wish to continue medical management. For patients who elect to be treated with debulking procedures as needed, use of locally‐administered adjuvant should be considered. Conclusion This proposed management algorithm from the RRPF serves as a contemporary resource and information guide for adult patients with RRP and their physicians considering treatment options. Level of Evidence 5
Biomimetic model for the identification of distinctive microenvironmental factors in glioblastoma radiosensitivity
Yao, Ryan , Rivera, Isabella , Maldonado, Jorge , Best‐Popescu, Catherine , Xu, Hui, Sarkaria, Jann N., Lu, Yi, Selting, Kim A. , Harley, Brendan A.C. , Pedron-Haba, Sara, Best-Popescu, Catherine A , Selting, Kim A , Harley, Brendan A C , Pedrón-Haba, Sara , Xu, Hui , Sarkaria, Jann N. , Wang, Jing-Xiang , Pedrón, Sara

Mayo Clinic

No container title available | January 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.14.699525 | PMID 41648585 Get It

Abstract Radiation therapy (RT) has long been included in the treatment of glioblastoma (GBM). However, radioresistance in cancer cells as well as toxicity in normal tissues are major obstacles to clinical efficacy. Improved understanding of the mechanisms of tumor microenvironment-induced radioresistance during and after radiation therapy can provide fundamental insights to improve clinical outcomes in GBM. Here, using three-dimensional engineered hydrogel models in vitro, we report the influence of extracellular matrix, hypoxia, and adjacent neuronal cells in radiotherapeutic sensitivity. We find that mechanical cues and oxygen availability regulate cellular response to radiation, with softer matrices allowing for more DNA damage. Hyaluronan fragments from the extracellular matrix also modulate rapid metabolic response to radiation, especially in hypoxic environments. We show that neuronal networks influence tumor metabolic activity and the inflammatory response. Overall, we demonstrate here that alternative radiation strategies, such as low dose rate radiation therapy and microenvironmental regulation, have the potential to be more effective in a specific subset of radiosensitive GBM tumors.
Achieving Expert-Level Clinical Infection Detection with LLMs from Clinical Documents: Validation in Complex Patient Cases with Cirrhosis
Yu, Yufei , Ford, James, Kim, Eileen , Patel, Avi, Loomba, Rohit, Malhotra, Atul, Nemati, Shamim, Ahn, Joseph C, Ford, James Stephen , Wardi, Gabriel , Malhotra, Atul , Nemati, Shamim

Mayo Clinic

No container title available | January 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.01.13.26344046 | PMID 41646769 Get It

ABSTRACT Background Systemic infections are a leading cause of hospitalization and death among patients with cirrhosis. Timely and accurate infection identification is essential for both clinical care and the development of predictive models. However, existing methods such as ICD-10 coding are unreliable, and manual chart review is resource-intensive and difficult to scale. This study aimed to develop and validate an automated large language model (LLM)-based approach for infection classification and subtyping in patients with cirrhosis presenting to the emergency department (ED). Method We developed INFEHR (INfection identification and subtyping using Free-text EHR analysis), an LLM-powered pipeline utilizing Claude 3.5 Sonnet to analyze clinical notes from the first 72 hours of admission. Model outputs were compared against a physician-adjudicated gold standard in a cohort of 1,000 encounters from patients with cirrhosis who presented to the ED. Performance was benchmarked against ICD-10 code–based labeling and CDC Adult Sepsis Event criteria. Results INFEHR achieved 94.7% overall accuracy, with 99.5% sensitivity and 92.8% positive predictive value for identifying infection presence, outperforming ICD-10–based classification across all metrics ( p < 0.0001). The model also demonstrated strong performance in classifying pathogen type and infection site. This pipeline processed notes within seconds, offering improvements in efficiency and scalability over manual review. Conclusion INFEHR offers a scalable, reproducible, and accurate method for infection phenotyping in cirrhosis. By overcoming limitations of traditional coding and manual review, it supports high-throughput infection surveillance, improves cohort construction for clinical research, and enables future integration into real-time decision-support tools in hepatology.
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET -Altered Solid Tumors: Analysis of the RETgistry Global Consortium
Waliany, Sarah , Cooper, Alissa J. , Liu, Stephen V. , Gautschi, O., Rotow, Julia K. , Smith, Katherine E. , Weber, Urs, Lee, Dae Ho , Loong, H., Patel, Jyoti D. , Nagasaka, Misako , Patel, Shetal , Tan, Daniel S. W., Solomon, Benjamin J., Pall, Georg , Riess, Jonathan W. , Sun, Lova , Früh, Martin, Uy, Natalie F., Gadgeel, Shirish, Feng, Jamie, Leighl, Natasha B., Baik, Christina S. , Lai, G., Ou, S. Ignatius, Cheung, Kingsley S.Y., Patil, Tejas, Weiler, Daniela , Yeap, Beow Y., Wirth, Lori J. , Gainor, Justin F., Drilon, Alexander D., Lin, Jessica J., Loong, Herbert H. , Rotow, Julia , Gautschi, Oliver , Smith, Katherine E R , Weber, Urs M , Loong, Herbert H , Pennell, Nathan A , Nagasaka, Misako , Patel, Shetal A , Tan, Daniel S W , Solomon, Benjamin J , Kim, Tae Min , Pall, Georg , Riess, Jonathan W , Sun, Lova , Früh, Martin , Uy, Natalie F , Gadgeel, Shirish , Feng, Jamie , Do, Andrew , Falcon, Christina , Leighl, Natasha B , Baik, Christina S , Lai, Gillianne G Y , Ou, Sai-Hong I , Cheung, Kingsley S Y , Patil, Tejas , Mansfield, Aaron S , Weiler, Daniela , Yeap, Beow Y , Wirth, Lori J , Gainor, Justin F , Drilon, Alexander , Lin, Jessica J , Liu, Stephen V , Früh, Martin , Gadgeel, Shirish M. , Feng, Jamie , Mansfield, Aaron S. , Gainor, Justin F.

Mayo Clinic

Clinical Cancer Research | January 15, 2026 | Volume: 32 | Issue: 6 | Pages: 1157-1168

10.1158/1078-0432.ccr-25-4382 | PMID 41537704 Get It

Abstract Purpose: Rearranged during transfection (RET) alterations are oncogenic drivers across solid tumors. Selective RET inhibitors (SRI) selpercatinib and pralsetinib have transformed outcomes for patients with RET-altered malignancies. Limited knowledge exists on genomic mechanisms of resistance to SRI. Experimental Design: We established “RETgistry,” a global consortium of patients with advanced RET-altered solid tumors who received SRI and underwent postprogression tissue or plasma biopsies assessed by next-generation sequencing. Frequencies of secondary RET resistance mutations and acquired non-RET gene alterations were determined. Progression-free survival (PFS) and time to treatment discontinuation (TTD) on first SRI were estimated with the Kaplan–Meier method. Results: RETgistry included 109 patients with RET-altered advanced solid tumors (lung, n = 94; thyroid, n = 15) who underwent 143 post-SRI progression biopsies (tissue, 91; plasma, 52). The median PFS and TTD were 13.9 months [95% confidence interval (CI), 10.1–16.6] and 17.3 months (95% CI, 14–20.2), respectively. Secondary RET mutations were detected in 20 (14%) biopsies [lung cancer, 15 (12.4%) and thyroid carcinoma, 5 (22.7%)]. Common acquired off-target alterations involved MET (18.2%; amplification, 15%), TP53 (8.2%), APC (7.6%), KRAS (7.1%), KEAP1 (5.9%), and CDKN2A/B (5.3%). MET alterations were enriched in post-SRI versus pre-SRI specimens (full cohort, 17.6% vs. 2.0%, P = 0.022; lung cancer, 19.1% vs. 2.1%, P = 0.022). Conclusions: The prevalence of secondary RET mutations after SRI was low, underscoring a greater role for off-target resistance. Recurrent acquired alterations involving tumor suppressor genes or upstream regulators of MAPK and PI3K pathways were identified, most commonly MET amplification. Continued efforts to characterize SRI resistance biology are critical to guide the development of novel therapeutic strategies.
Addressing Transplant Policy Shortcomings Utilizing a Relational Leadership Model
Beaman, Lindsay R. , Kim, Christopher H. , Diwan, Tayyab S., Diwan, Tayyab , Beaman, Lindsay , Diwan, Tayyab S.

Mayo Clinic

The American Journal of Bioethics | January 14, 2026 | Volume: 26 | Issue: 1 | Pages: 101-103

10.1080/15265161.2025.2594430 | PMID 41533110 Get It